NCT05046197 is a clinical trial in Advance Care Planning, sponsored by University of Warwick.

Who is sponsoring NCT05046197?

NCT05046197 is sponsored by University of Warwick.

What condition does NCT05046197 study?

NCT05046197 studies Advance Care Planning.

Is NCT05046197 still recruiting?

NCT05046197 is currently completed. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT05046197

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Integration of the Recommended Summary Plan for Emergency Care Treatment (ReSPECT) Into Primary Care

Completed Last updated 29 November 2023

What this trial tests

trial in Advance Care Planning in 298 participants. Completed in 31 July 2023.

Timeline

19 September 2021

Primary endpoint
31 July 2023

31 July 2023

Quick facts

Lead sponsor	University of Warwick
Status	Completed
Study type	OBSERVATIONAL
Enrollment	298
Start date	19 September 2021
Primary completion	31 July 2023
Estimated completion	31 July 2023
Sites	1 location across United Kingdom

Conditions studied

Advance Care Planning — all drugs for Advance Care Planning →

Sponsor

University of Warwick

Who can join

Adults 18 to 115, any sex, with Advance Care Planning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

When a person becomes seriously ill health professionals treating them need to make decisions quickly. They may have limited information about the person's medical history or about their wishes about treatment. To help health care professionals decide what is the best treatment for that person Emergency Care Treatment Plans can be used. These record what the person would or would not want to happen in certain situations. The plans are usually written by the person's doctor after discussing it with them. One type of plan, called ReSPECT (Recommended Summary Plan for Emergency Care and Treatment) is used in many National Health Service hospitals in the UK. However, it might be better to write these plans when the person is living at home before they are admitted to hospital. ReSPECT forms are now being used by GPs and other primary care staff in the UK. This project plans to study the ReSPECT process in primary care to determine how, when, and why it is used, and what effect it has on patient treatment and care. It will use a mixture of methods for collecting information. The investigators will interview patients, their families, GPs and care home managers to ask them about their experience of the ReSPECT process. To get a wider range of views, the investigators will also speak to groups of other health professionals, patient organisations and faith leaders, and carry out national surveys of GPs and the general public. The study will also look how at patient records to see how the ResPECT process makes a difference to decisions about medical treatment when a person is seriously ill. The information from these different methods will be brought together at a stakeholder meeting and will be used to work out how the ReSPECT process can work best to improve patient treatment and care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Using the Recommended Summary Plan for Emergency Care and Treatment in Primary Care: a mixed methods study.
Slowther AM, Harlock J, Bernstein CJ, Bruce K, et al · · 2024 · cited 5× · PMID 39487818 · DOI 10.3310/nvtf7521

Verify or expand the search:

Other recruiting trials for Advance Care Planning

Currently open trials in the same condition.

NCT07235839 — The Impact of an Advance Care Planning Game on Life-Sustaining Treatment Preferences, Depression, and Hope in Older Adul · NA · active not recruiting
NCT07134881 — Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE) · NA · recruiting
NCT06538493 — Jumpstarting Advance Care Planning With ANAI People · NA · recruiting
NCT06731361 — Improved Prescribing for Older Nursing Home Patients · NA · recruiting
NCT06376799 — Which Health-care Professional(s) to Talk About Advance Care Planning ? · recruiting

Other University of Warwick trials

Trials by the same sponsor.

NCT06334718 — Drone Delivered Defibrillators (The 3D Project). · completed
NCT05402436 — Breast Screening Atypia and Subsequent Development of Cancer in England · completed
NCT04977414 — Making Data Count Intervention Evaluation · NA · completed
NCT05247463 — English Mammography Screening Outcomes by Age, Frequency and Test Threshold · unknown
NCT04546854 — Influenza 2020/2021 · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05046197 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Warwick
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05046197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing